|
|
Double umbilical cord blood transplantation for hematological malignancies: a long- term analysis from the SFGM-TC registry.
Hélène Labussière Wallet
,
Mohamad Sobh
,
Stéphane Morisset
,
Marie Robin
,
Nathalie Fegueux
et al.
Journal articles
hal-00849674v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.
Gandhi Damaj
,
Alain Duhamel
,
Marie Robin
,
Yves Beguin
,
Mauricette Michallet
et al.
Journal articles
inserm-00821506v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.
Philippe Moreau
,
Frédéric Garban
,
Michel Attal
,
Mauricette Michallet
,
Gérald Marit
et al.
Journal articles
hal-00821148v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Mauricette Michallet
,
Quoc-Hung Le
,
Mohamad Mohty
,
Thomas Prébet
,
Franck Nicolini
et al.
Journal articles
istex
inserm-00484237v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Marie Robin
,
Reza Tabrizi
,
Mohamad Mohty
,
Sabine Furst
,
Mauricette Michallet
et al.
Journal articles
hal-00849650v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup
A. Hospital
,
T. Prebet
,
S. Bertoli
,
X. Thomas
,
E. Tavernier
et al.
Journal articles
hal-01688071v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial
Nicolas Boissel
,
Aline Renneville
,
Thibaut Leguay
,
Pascale Cornillet Lefebvre
,
Christian Recher
et al.
Journal articles
inserm-01820455v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience
Hervé Avet-Loiseau
,
Cyrille Hulin
,
Loic Campion
,
Philippe Rodon
,
Gerald Marit
et al.
Journal articles
hal-01064339v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
Jean-Luc Harousseau
,
Herve Avet-Loiseau
,
Michel Attal
,
Catherine Charbonnel
,
Frederic Garban
et al.
Journal articles
hal-00821143v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.
Patrice Chevallier
,
Richard M Szydlo
,
Didier Blaise
,
Reza Tabrizi
,
Mauricette Michallet
et al.
Journal articles
hal-00849660v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.
Bruno Lioure
,
Marie C Béné
,
Arnaud Pigneux
,
Anne Huynh
,
Patrice Chevallier
et al.
Journal articles
hal-00849702v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study
A. Desjonqueres
,
P. Chevallier
,
X. Thomas
,
F. Huguet
,
T. Leguay
et al.
Journal articles
hal-01792626v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience
Marie-Anne Couturier
,
Françoise Huguet
,
Patrice Chevallier
,
Felipe Suarez
,
Xavier Thomas
et al.
Journal articles
hal-01231425v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02
Xavier Leleu
,
Michel Attal
,
Bertrand Arnulf
,
Philippe Moreau
,
Catherine Traulle
et al.
Journal articles
hal-01064417v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
Michel Attal
,
Valerie Lauwers-Cances
,
Gerald Marit
,
Denis Caillot
,
Philippe Moreau
et al.
Journal articles
hal-00852275v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|